Microarrays for the functional analysis of the chemical-kinase interactome

被引:29
作者
Horiuchi, KY
Wang, Y
Diamond, SL
Ma, HC
机构
[1] React Biol Corp, Malvern, PA 19355 USA
[2] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA
关键词
chemical microarray; kinase profiling; functional assay; high-throughput screening (HTS); ELISA;
D O I
10.1177/1087057105282097
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A central challenge in chemical biology is profiling the activity of a large number of chemical structures against hundreds of biological targets, such as kinases. Conventional P-32-incorporation or immunoassay of phosphorylated residues produces high-quality signals for monitoring kinase reactions but is difficult to use in high-throughput screening (HTS) because of cost and the need for well-plate washing. The authors report a method for densely archiving compounds in nanodroplets on peptide or protein substrate-coated microarrays for subsequent profiling by aerosol deposition of kinases. Each microarray contains over 6000 reaction centers (1.0 nL each) whose phosphorylation progress can be detected by immunofluorescence. For p60(c-src), the microarray produced a signal-to-background ratio of 36.3 and Z' factor of 0.63 for HTS and accurate enzyme kinetic parameters (K-m(ATP) = 3.3 mu M) and IC50 values for staurosporine (210 nM) and PP2 (326 nM) at 10 mu M adenosine triphosphate (ATP). Similarly, B-Raf phosphorylation of MEK-coated microarrays was inhibited in the nanoliter reactions by GW5074 at the expected IC50 of 9 nM. Common kinase inhibitors were printed on microarrays, and their inhibitory activities were systematically profiled against B-Raf (V599E), KDR, Met, Flt-3 (D835Y), Lyn, EGFR, PDGFR beta, and Tie2. All results indicate that this platform is well suited for kinetic analysis, HTS, large-scale IC50 determinations, and selectivity profiling.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 34 条
[1]   ENERGETIC LIMITS OF PHOSPHOTRANSFER IN THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE AS MEASURED BY VISCOSITY EXPERIMENTS [J].
ADAMS, JA ;
TAYLOR, SS .
BIOCHEMISTRY, 1992, 31 (36) :8516-8522
[2]   Microarrayed compound screening (μARCS) to identify activators and inhibitors of AMP-activated protein kinase [J].
Anderson, SN ;
Cool, BL ;
Kifle, L ;
Chiou, W ;
Egan, DA ;
Barrett, LW ;
Richardson, PL ;
Frevert, EU ;
Warrior, U ;
Kofron, JL ;
Burns, DJ .
JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (02) :112-121
[3]   Chemical clamping allows for efficient phosphorylation of the RNA carrier protein Npl3 [J].
Aubol, BE ;
Ungs, L ;
Lukasiewicz, R ;
Ghosh, G ;
Adams, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) :30182-30188
[4]   Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays [J].
Beasley, JR ;
McCoy, PM ;
Walker, TL ;
Dunn, DA .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2004, 2 (02) :141-151
[5]   Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics [J].
Blum, G ;
Gazit, A ;
Levitzki, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40442-40454
[6]  
BOGUSLAVSKY J, 2004, BIO IT WORLD TO 0519
[7]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[8]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[9]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[10]   Alternative binding modes of an inhibitor to two different kinases [J].
De Moliner, E ;
Brown, NR ;
Johnson, LN .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (15) :3174-3181